{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:46:40Z","timestamp":1791935200578,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["AG079336"],"award-info":[{"award-number":["AG079336"]}]},{"name":"NIH","award":["AG057842"],"award-info":[{"award-number":["AG057842"]}]},{"name":"NIH","award":["AG094068"],"award-info":[{"award-number":["AG094068"]}]},{"name":"NIH","award":["R35ES030443"],"award-info":[{"award-number":["R35ES030443"]}]},{"name":"NIH","award":["U54NS127758"],"award-info":[{"award-number":["U54NS127758"]}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","award":["A25-1690"],"award-info":[{"award-number":["A25-1690"]}],"id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25PRE1365157"],"award-info":[{"award-number":["25PRE1365157"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25POST1363814"],"award-info":[{"award-number":["25POST1363814"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","award":["TRIBA\/ Physiology Faculty Startup Fund"],"award-info":[{"award-number":["TRIBA\/ Physiology Faculty Startup Fund"]}],"id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes mellitus (DM) is a major risk factor contributing to the development of Alzheimer's disease-related dementias (ADRD). While one of the early symptoms of both Alzheimer\u2019s disease (AD) and DM-related ADRD is a reduction in cerebral blood flow, the underlying biological mechanisms driving this decline remain to be fully elucidated. Genome-wide association studies have linked AD\/ADRD to single-nucleotide polymorphisms in the gene encoding soluble epoxide hydrolase (sEH), an enzyme we previously reported to be upregulated in the brains of an AD rat model. Our previous studies also demonstrated that chronic sEH inhibition with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) preserves hippocampal-dependent spatial learning and memory and improves cerebral hemodynamics in both AD and DM-ADRD models. In the present study, we found that chronic TPPU treatment (1\u00a0mg\/kg\/day) reduced sEH expression in the brain, improved cortical-based non-spatial recognition memory involving both cortical and hippocampal networks, and reduced anxiety in DM-ADRD rats. TPPU improved brain perfusion and normalized impaired whisker-evoked functional hyperemia, an effect associated with increased Kir2.1 expression and neurovascular coupling in cerebral capillaries. Furthermore, TPPU increased tight junction protein expression (ZO-1 and OCLN), mitigated capillary rarefaction, and suppressed astrocyte and microglial activation in DM-ADRD rats. At the cellular level, TPPU attenuated hippocampal neurodegeneration, restored the expression of synaptic proteins (PSD95 and SY38), and reduced levels of proinflammatory chemokines, including MCP-1, RANTES, and MIP-1\u03b1, in the hippocampus of DM-ADRD rats. In conclusion, TPPU preserves cognitive function in DM-ADRD by mitigating cerebrovascular dysfunction, neuroinflammation and gliosis, thereby preserving synaptic integrity and neuronal survival, and represents a promising therapeutic strategy for DM-ADRD.<\/jats:p>","DOI":"10.1007\/s11357-026-02591-3","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:05:14Z","timestamp":1791878714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of soluble epoxide hydrolase rescues cognitive deficits by preserving neurovascular integrity and attenuating glial and neuropathology in diabetic-related dementia"],"prefix":"10.1007","author":[{"given":"Xing","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Border","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Hanscom-Trofy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-3610","authenticated-orcid":false,"given":"Fan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5581-0217","authenticated-orcid":false,"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"e29120","DOI":"10.7759\/cureus.29120","volume":"14","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Agrawal AK. Pathophysiological Association Between Diabetes Mellitus and Alzheimer\u2019s Disease. Cureus. 2022;14:e29120. https:\/\/doi.org\/10.7759\/cureus.29120.","journal-title":"Cureus"},{"key":"2591_CR2","doi-asserted-by":"publisher","first-page":"e70235","DOI":"10.1002\/alz.70235","volume":"29","author":"Alzheimer's disease facts and figures","year":"2025","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2025;29:e70235. https:\/\/doi.org\/10.1002\/alz.70235.","journal-title":"Alzheimers Dement"},{"key":"2591_CR3","doi-asserted-by":"publisher","first-page":"1736410","DOI":"10.3389\/fendo.2026.1736410","volume":"17","author":"J Wu","year":"2026","unstructured":"Wu J, Li J, Qin X, Chen W. Association between diabetes mellitus and risk of Alzheimer\u2019s disease: a meta-analysis and systematic review. Front Endocrinol (Lausanne). 2026;17:1736410. https:\/\/doi.org\/10.3389\/fendo.2026.1736410.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2591_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11357-021-00357-7","volume":"43","author":"F Fan","year":"2021","unstructured":"Fan F, Roman RJ. Reversal of cerebral hypoperfusion: a novel therapeutic target for the treatment of AD\/ADRD? Geroscience. 2021;43:1065\u20137. https:\/\/doi.org\/10.1007\/s11357-021-00357-7.","journal-title":"Geroscience"},{"key":"2591_CR5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s11357-023-00773-x","volume":"45","author":"X Fang","year":"2023","unstructured":"Fang X, Tang C, Zhang H, Border JJ, Liu Y, Shin SM, et al. Longitudinal characterization of cerebral hemodynamics in the TgF344-AD rat model of Alzheimer\u2019s disease. Geroscience. 2023;45:1471\u201390. https:\/\/doi.org\/10.1007\/s11357-023-00773-x.","journal-title":"Geroscience"},{"key":"2591_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11357-020-00233-w","volume":"42","author":"S Wang","year":"2020","unstructured":"Wang S, Lv W, Zhang H, Liu Y, Li L, Jefferson JR, et al. Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats. Geroscience (New York NY). 2020;42:1387\u2013410. https:\/\/doi.org\/10.1007\/s11357-020-00233-w.","journal-title":"Geroscience (New York NY)"},{"key":"2591_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-026-10210-x","author":"M Anwer","year":"2025","unstructured":"Anwer M, Poliakova T, Albanus RD, Bhuiyan MIH, Brickman AM, Chaudhuri S, et al. Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory. Mamm Genome. 2025. https:\/\/doi.org\/10.1007\/s00335-026-10210-x.","journal-title":"Mamm Genome"},{"key":"2591_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140:793\u2013810. https:\/\/doi.org\/10.1007\/s00401-020-02215-w.","journal-title":"Acta Neuropathol"},{"key":"2591_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-026-01964-2","author":"SH Kang","year":"2026","unstructured":"Kang SH, Kim S, Kim YJ, Yoo H, Lee EH, Jang H, et al. Glymphatic dysfunction links vascular pathology to Alzheimer\u2019s biomarkers and cognitive decline. Alzheimers Res Ther. 2026. https:\/\/doi.org\/10.1186\/s13195-026-01964-2.","journal-title":"Alzheimers Res Ther"},{"key":"2591_CR10","doi-asserted-by":"publisher","first-page":"1077302","DOI":"10.3389\/fragi.2022.1077302","volume":"3","author":"S Wang","year":"2022","unstructured":"Wang S, Tang C, Liu Y, Border JJ, Roman RJ, Fan F. Impact of impaired cerebral blood flow autoregulation on cognitive impairment. Front Aging. 2022;3:1077302. https:\/\/doi.org\/10.3389\/fragi.2022.1077302.","journal-title":"Front Aging"},{"key":"2591_CR11","doi-asserted-by":"publisher","unstructured":"Fan F, Zhao N, Guo M. Lymphatic-venous anastomosis: Cracking the code of Alzheimer's disease treatment? Neural Regen Res. 2025.\u00a0https:\/\/doi.org\/10.4103\/NRR.NRR-D-4125-00540.","DOI":"10.4103\/NRR.NRR-D-4125-00540"},{"key":"2591_CR12","doi-asserted-by":"publisher","first-page":"R379","DOI":"10.1152\/ajpregu.00256.2014","volume":"308","author":"F Fan","year":"2015","unstructured":"Fan F, Geurts AM, Murphy SR, Pabbidi MR, Jacob HJ, Roman RJ. Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol. 2015;308:R379-390. https:\/\/doi.org\/10.1152\/ajpregu.00256.2014.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2591_CR13","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang S, Guo Y, Zhang H, Roman RJ, Fan F. Impaired Pericyte Constriction and Cerebral Blood Flow Autoregulation in Diabetes. Stroke. 2020;51:AWP498\u2013AWP498.","DOI":"10.1161\/str.51.suppl_1.WP498"},{"key":"2591_CR14","first-page":"555587","volume":"2","author":"S Shekhar","year":"2017","unstructured":"Shekhar S, Wang S, Mims PN, Gonzalez-Fernandez E, Zhang C, He X, et al. Impaired Cerebral Autoregulation-A Common Neurovascular Pathway in Diabetes may Play a Critical Role in Diabetes-Related Alzheimer\u2019s Disease. Curr Res Diabetes Obes J. 2017;2:555587.","journal-title":"Curr Res Diabetes Obes J"},{"key":"2591_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11357-020-00179-z","volume":"42","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang S, Liu Y, Fan L, Booz GW, Roman RJ, et al. Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction. Geroscience. 2020;42:547\u201361. https:\/\/doi.org\/10.1007\/s11357-020-00179-z.","journal-title":"Geroscience"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"22290","DOI":"10.1073\/pnas.1011321108","volume":"107","author":"F Fernandez-Klett","year":"2010","unstructured":"Fernandez-Klett F, Offenhauser N, Dirnagl U, Priller J, Lindauer U. Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci U S A. 2010;107:22290\u20135. https:\/\/doi.org\/10.1073\/pnas.1011321108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2591_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/01.str.29.1.229","volume":"29","author":"DR Harder","year":"1998","unstructured":"Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, Roman RJ. Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke. 1998;29:229\u201334. https:\/\/doi.org\/10.1161\/01.str.29.1.229.","journal-title":"Stroke"},{"key":"2591_CR18","doi-asserted-by":"publisher","first-page":"H549","DOI":"10.1152\/ajpheart.00726.2020","volume":"320","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang H, Wang S, Guo Y, Fang X, Zheng B, et al. Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction. Am J Physiol Heart Circ Physiol. 2021;320:H549\u201362. https:\/\/doi.org\/10.1152\/ajpheart.00726.2020.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2591_CR19","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s11357-023-00841-2","volume":"45","author":"X Fang","year":"2023","unstructured":"Fang X, Border JJ, Rivers PL, Zhang H, Williams JM, Fan F, et al. Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling. Geroscience. 2023;45:2909\u201326. https:\/\/doi.org\/10.1007\/s11357-023-00841-2.","journal-title":"Geroscience"},{"key":"2591_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.33696\/neurol.2.048","volume":"2","author":"R Crumpler","year":"2021","unstructured":"Crumpler R, Roman RJ, Fan F. Capillary Stalling: A Mechanism of Decreased Cerebral Blood Flow in AD\/ADRD. J Exp Neurol. 2021;2:149\u201353. https:\/\/doi.org\/10.33696\/neurol.2.048.","journal-title":"J Exp Neurol"},{"key":"2591_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0271678x221076568","volume":"42","author":"J-H Yoon","year":"2022","unstructured":"Yoon J-H, Shin P, Joo J, Kim GS, Oh W-Y, Jeong Y. Increased capillary stalling is associated with endothelial glycocalyx loss in subcortical vascular dementia. J Cereb Blood Flow Metab. 2022;42:1383\u201397. https:\/\/doi.org\/10.1177\/0271678x221076568.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2591_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-022-00999-5","volume":"14","author":"M Simon","year":"2022","unstructured":"Simon M, Wang MX, Ismail O, Braun M, Schindler AG, Reemmer J, et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid \u03b2 plaque formation in mice. Alzheimers Res Ther. 2022;14:59. https:\/\/doi.org\/10.1186\/s13195-022-00999-5.","journal-title":"Alzheimers Res Ther"},{"key":"2591_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13550-025-01339-y","volume":"16","author":"H Xue","year":"2025","unstructured":"Xue H, Bi S, Chen Z, He Y, Xu W, Xu X, et al. Glymphatic system dysfunction mediates amyloid deposition and cognitive impairment in Alzheimer\u2019s disease: a PET\/MRI multimodality imaging study. EJNMMI Res. 2025;16:2. https:\/\/doi.org\/10.1186\/s13550-025-01339-y.","journal-title":"EJNMMI Res"},{"key":"2591_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.087887","volume":"20","author":"F Cheng","year":"2025","unstructured":"Cheng F, Hou Y, Zhang P, Fan F, Haines JL, Pieper AA, et al. Alzheimer\u2019s disease genetics and real\u2010world patient data fuel target and drug discovery in European and African American ancestries using AI\/ML approaches. Alzheimers Dement. 2025;20:e087887.","journal-title":"Alzheimers Dement"},{"key":"2591_CR25","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1007\/s11357-025-01550-8","volume":"47","author":"C Tang","year":"2025","unstructured":"Tang C, Border JJ, Zhang H, Gregory A, Bai S, Fang X, et al. Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer\u2019s disease and diabetes-related dementia rat models. Geroscience. 2025;47:4429\u201349. https:\/\/doi.org\/10.1007\/s11357-025-01550-8.","journal-title":"Geroscience"},{"key":"2591_CR26","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-5716817\/v1","author":"F Cheng","year":"2024","unstructured":"Cheng F, Hou Y, Zhang P, Li Y, Lorincz-Comi N, Fan F, et al. Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer\u2019s disease. Research Square (Preprint). 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-5716817\/v1.","journal-title":"Research Square (Preprint)"},{"key":"2591_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.neurobiolaging.2006.12.011","volume":"29","author":"SL Ma","year":"2008","unstructured":"Ma SL, Tang NL, Zhang YP, Ji LD, Tam CW, Lui VW, et al. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer\u2019s disease in Chinese. Neurobiol Aging. 2008;29:856\u201360. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.12.011.","journal-title":"Neurobiol Aging"},{"key":"2591_CR28","unstructured":"Fan F, Simino J, Auchus AP, Knopman DS, Boerwinkle E, Fornage M, Mosley TH, Roman RJ. Functional variants in CYP4A11 and CYP4F2 are associated with cognitive impairment and related dementia endophenotypes in the elderly. In: The 16th International Winter Eicosanoid Conference; 2016;Baltimore, MD. p. CV5."},{"key":"2591_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","volume":"72","author":"RJ Roman","year":"2018","unstructured":"Roman RJ, Fan F. 20-HETE: hypertension and beyond. Hypertension. 2018;72:12\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.10269.","journal-title":"Hypertension"},{"key":"2591_CR30","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00119.2021","author":"E Gonzalez-Fernandez","year":"2021","unstructured":"Gonzalez-Fernandez E, Fan L, Wang S, Liu Y, Gao W, Thomas KN, et al. The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases. Physiol Genomics. 2021. https:\/\/doi.org\/10.1152\/physiolgenomics.00119.2021.","journal-title":"Physiol Genomics"},{"key":"2591_CR31","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00529.2016","volume":"312","author":"F Fan","year":"2017","unstructured":"Fan F, Pabbidi MR, Ge Y, Li L, Wang S, Mims PN, et al. Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries. Am J Physiol Renal Physiol. 2017;312:F971\u201381. https:\/\/doi.org\/10.1152\/ajprenal.00529.2016.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2591_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411843","author":"GK Mansour","year":"2025","unstructured":"Mansour GK, Bolgova O, Hajjar AW, Mavrych V. Neurovascular dysfunction and glymphatic impairment: an unexplored therapeutic frontier in neurodegeneration. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms262411843.","journal-title":"Int J Mol Sci"},{"key":"2591_CR33","doi-asserted-by":"publisher","first-page":"837649","DOI":"10.3389\/fnagi.2022.837649","volume":"14","author":"CX Gong","year":"2022","unstructured":"Gong CX, Dai CL, Liu F, Iqbal K. Multi-targets: an unconventional drug development strategy for Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:837649. https:\/\/doi.org\/10.3389\/fnagi.2022.837649.","journal-title":"Front Aging Neurosci"},{"key":"2591_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-025-00828-x","volume":"20","author":"MR Duggan","year":"2025","unstructured":"Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Pe\u00f1a A, Tansey MG, et al. Immune modulation to treat Alzheimer\u2019s disease. Mol Neurodegener. 2025;20:39. https:\/\/doi.org\/10.1186\/s13024-025-00828-x.","journal-title":"Mol Neurodegener"},{"key":"2591_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052945","author":"T Yamashita","year":"2024","unstructured":"Yamashita T, Abe K. Update on antioxidant therapy with edaravone: expanding applications in neurodegenerative diseases. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25052945.","journal-title":"Int J Mol Sci"},{"key":"2591_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15020164","author":"SM Lomel\u00ed Mart\u00ednez","year":"2025","unstructured":"Lomel\u00ed Mart\u00ednez SM, Pacheco Mois\u00e9s FP, Bitzer-Quintero OK, Ram\u00edrez-Jirano J, Delgado-Lara DLC, Cort\u00e9s Trujillo I, et al. Effect of N-acetyl cysteine as an adjuvant treatment in Alzheimer\u2019s disease. Brain Sci. 2025. https:\/\/doi.org\/10.3390\/brainsci15020164.","journal-title":"Brain Sci"},{"key":"2591_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092073","author":"M Abdalla","year":"2025","unstructured":"Abdalla M, Ibrahim M, Alkorbi N, Alkuwari S, Pedersen S, Rathore HA. Epoxide hydrolase inhibitors for the treatment of Alzheimer\u2019s disease and other neurological disorders: a comprehensive review. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13092073.","journal-title":"Biomedicines"},{"key":"2591_CR38","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4103\/NRR.NRR-D-24-00503","volume":"20","author":"A Gregory","year":"2025","unstructured":"Gregory A, Tang C, Fan F. Soluble epoxide hydrolase: a next-generation drug target for Alzheimer\u2019s disease and related dementias. Neural Regen Res. 2025;20:2585\u20136.","journal-title":"Neural Regen Res"},{"key":"2591_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062433","author":"X Fang","year":"2025","unstructured":"Fang X, Border JJ, Zhang H, Challagundla L, Kaur J, Hwang SH, et al. A soluble epoxide hydrolase inhibitor improves cerebrovascular dysfunction, neuroinflammation, amyloid burden, and cognitive impairments in the hAPP\/PS1 TgF344-AD rat model of Alzheimer\u2019s disease. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26062433.","journal-title":"Int J Mol Sci"},{"key":"2591_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-026-02140-y","author":"GC Morgan","year":"2026","unstructured":"Morgan GC, Gregory A, Tang C, Hwang SH, Border JJ, Xu J, et al. PTUPB improves cognitive function in Alzheimer\u2019s disease associated with enhancing cerebral vascular myogenic response and attenuating vascular remodeling. Geroscience. 2026. https:\/\/doi.org\/10.1007\/s11357-026-02140-y.","journal-title":"Geroscience"},{"key":"2591_CR41","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1007\/s12035-020-02044-8","volume":"57","author":"GC Rosu","year":"2020","unstructured":"Rosu GC, Catalin B, Balseanu TA, Laurentiu M, Claudiu M, Kumar-Singh S, et al. Inhibition of Aquaporin 4 Decreases Amyloid A\u03b240 Drainage Around Cerebral Vessels. Mol Neurobiol. 2020;57:4720\u201334. https:\/\/doi.org\/10.1007\/s12035-020-02044-8.","journal-title":"Mol Neurobiol"},{"key":"2591_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/wnr.0000000000000990","volume":"29","author":"VJ Huber","year":"2018","unstructured":"Huber VJ, Igarashi H, Ueki S, Kwee IL, Nakada T. Aquaporin-4 facilitator TGN-073 promotes interstitial fluid circulation within the blood-brain barrier: [17O]H2O JJVCPE MRI study. NeuroReport. 2018;29:697\u2013703. https:\/\/doi.org\/10.1097\/wnr.0000000000000990.","journal-title":"NeuroReport"},{"key":"2591_CR43","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s11357-024-01061-y","volume":"46","author":"C Tang","year":"2024","unstructured":"Tang C, Zhang H, Border JJ, Liu Y, Fang X, Jefferson JR, et al. Impact of knockout of dual-specificity protein phosphatase 5 on structural and mechanical properties of rat middle cerebral arteries: implications for vascular aging. Geroscience. 2024;46:3135\u201347. https:\/\/doi.org\/10.1007\/s11357-024-01061-y.","journal-title":"Geroscience"},{"issue":"Suppl 1","key":"2591_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/alz70855_096815","volume":"21","author":"AP Gregory","year":"2025","unstructured":"Gregory AP, Morgan GC, Tang C, Zhang H, Border JJ, Fang X, et al. SGLT2 inhibition protects cognitive function in Alzheimer\u2019s disease by enhancing brain perfusion, independent of glucose control. Alzheimers Dement. 2025;21(Suppl 1):e096815. https:\/\/doi.org\/10.1002\/alz70855_096815.","journal-title":"Alzheimers Dement"},{"key":"2591_CR45","doi-asserted-by":"publisher","first-page":"H246","DOI":"10.1152\/ajpheart.00438.2021","volume":"322","author":"S Wang","year":"2022","unstructured":"Wang S, Jiao F, Border JJ, Fang X, Crumpler RF, Liu Y, et al. Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-month-old diabetic animals. Am J Physiol Heart Circ Physiol. 2022;322:H246\u201359. https:\/\/doi.org\/10.1152\/ajpheart.00438.2021.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2591_CR46","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fphar.2019.00288","volume":"10","author":"R Pardeshi","year":"2019","unstructured":"Pardeshi R, Bolshette N, Gadhave K, Arfeen M, Ahmed S, Jamwal R, et al. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer\u2019s Disease-Like Complications of Diabetes. Front Pharmacol. 2019;10:288. https:\/\/doi.org\/10.3389\/fphar.2019.00288.","journal-title":"Front Pharmacol"},{"key":"2591_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","volume":"77","author":"JD Imig","year":"2016","unstructured":"Imig JD. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Adv Pharmacol. 2016;77:105\u201341. https:\/\/doi.org\/10.1016\/bs.apha.2016.04.003.","journal-title":"Adv Pharmacol"},{"key":"2591_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1369\/jhc.2008.950659","volume":"56","author":"P Sura","year":"2008","unstructured":"Sura P, Sura R, Enayetallah AE, Grant DF. Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem. 2008;56:551\u20139. https:\/\/doi.org\/10.1369\/jhc.2008.950659.","journal-title":"J Histochem Cytochem"},{"key":"2591_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","volume":"12","author":"MF Domingues","year":"2019","unstructured":"Domingues MF, Callai-Silva N, Piovesan AR, Carlini CR. Soluble epoxide hydrolase and brain cholesterol metabolism. Front Mol Neurosci. 2019;12:325. https:\/\/doi.org\/10.3389\/fnmol.2019.00325.","journal-title":"Front Mol Neurosci"},{"key":"2591_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbrc.2020.01.085","volume":"524","author":"J Wu","year":"2020","unstructured":"Wu J, Zhao Y, Fan Z, Chen Q, Chen J, Sun Y, et al. Soluble epoxide hydrolase inhibitor protects against blood-brain barrier dysfunction in a mouse model of type 2 diabetes via the AMPK\/HO-1 pathway. Biochem Biophys Res Commun. 2020;524:354\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.085.","journal-title":"Biochem Biophys Res Commun"},{"key":"2591_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2133\/dmpk.24.438","volume":"24","author":"A Oguro","year":"2009","unstructured":"Oguro A, Fujita N, Imaoka S. Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression. Drug Metab Pharmacokinet. 2009;24:438\u201345. https:\/\/doi.org\/10.2133\/dmpk.24.438.","journal-title":"Drug Metab Pharmacokinet"},{"key":"2591_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2018.05.004","volume":"136","author":"N Minaz","year":"2018","unstructured":"Minaz N, Razdan R, Hammock BD, Goswami SK. An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins Other Lipid Mediat. 2018;136:84\u20139. https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.05.004.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2591_CR53","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/ejn.15150","volume":"53","author":"J Wu","year":"2021","unstructured":"Wu J, Fan Z, Zhao Y, Chen Q, Xiao Q. Inhibition of soluble epoxide hydrolase (sEH) protects hippocampal neurons and reduces cognitive decline in type 2 diabetic mice. Eur J Neurosci. 2021;53:2532\u201340. https:\/\/doi.org\/10.1111\/ejn.15150.","journal-title":"Eur J Neurosci"},{"key":"2591_CR54","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/jm100691c","volume":"53","author":"TE Rose","year":"2010","unstructured":"Rose TE, Morisseau C, Liu JY, Inceoglu B, Jones PD, Sanborn JR, et al. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem. 2010;53:7067\u201375. https:\/\/doi.org\/10.1021\/jm100691c.","journal-title":"J Med Chem"},{"key":"2591_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.prostaglandins.2015.06.005","volume":"121","author":"AI Ostermann","year":"2015","unstructured":"Ostermann AI, Herbers J, Willenberg I, Chen R, Hwang SH, Greite R, et al. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Prostaglandins Other Lipid Mediat. 2015;121:131\u20137. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.06.005.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2591_CR56","doi-asserted-by":"crossref","unstructured":"Pabbidi MR, Mazur O, Fan F, Farley JM, Gebremedhinm D, Harder DR, Roman RJ. Enhanced large conductance K+ channel (BK) activity contributes to the impaired myogenic response in the cerebral vasculature of fawn-hooded-hypertensive rats. Am J Physiol Heart Circ Physiol. 2014;306(7):H989-H1000.","DOI":"10.1152\/ajpheart.00636.2013"},{"key":"2591_CR57","doi-asserted-by":"publisher","first-page":"F565","DOI":"10.1152\/ajprenal.00404.2012","volume":"304","author":"M Burke","year":"2013","unstructured":"Burke M, Pabbidi M, Fan F, Ge Y, Liu R, Williams JM, et al. Genetic basis of the impaired renal myogenic response in FHH rats. Am J Physiol Renal Physiol. 2013;304:F565-577. https:\/\/doi.org\/10.1152\/ajprenal.00404.2012.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2591_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14:149\u201356. https:\/\/doi.org\/10.1016\/s2213-8587(25)00299-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2591_CR59","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1161\/circulationaha.117.027448","volume":"136","author":"FJ Wolters","year":"2017","unstructured":"Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, et al. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136:719\u201328. https:\/\/doi.org\/10.1161\/circulationaha.117.027448.","journal-title":"Circulation"},{"key":"2591_CR60","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.18632\/aging.202963","volume":"13","author":"F Fan","year":"2021","unstructured":"Fan F, Booz GW, Roman RJ. Aging diabetes, deconstructing the cerebrovascular wall. Aging (Albany NY). 2021;13:9158\u20139. https:\/\/doi.org\/10.18632\/aging.202963.","journal-title":"Aging (Albany NY)"},{"key":"2591_CR61","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s11357-022-00591-7","volume":"44","author":"X Fang","year":"2022","unstructured":"Fang X, Zhang J, Roman RJ, Fan F. From 1901 to 2022, how far are we from truly understanding the pathogenesis of age-related dementia? GeroScience. 2022;44:1879\u201383. https:\/\/doi.org\/10.1007\/s11357-022-00591-7.","journal-title":"GeroScience"},{"key":"2591_CR62","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bbadis.2008.10.013","volume":"1792","author":"SA Wrighten","year":"2009","unstructured":"Wrighten SA, Piroli GG, Grillo CA, Reagan LP. A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochem Biophys Acta. 2009;1792:444\u201353. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.013.","journal-title":"Biochem Biophys Acta"},{"key":"2591_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech. 2022;12:55. https:\/\/doi.org\/10.1007\/s13205-022-03123-4.","journal-title":"3 Biotech"},{"key":"2591_CR64","doi-asserted-by":"publisher","unstructured":"Cochar-Soares N, de Oliveira DC, Luiz MM, Aliberti MJR, Suemoto CK, Steptoe A, de Oliveira C, Alexandre TS. Sex Differences in the Trajectories of Cognitive Decline and Affected Cognitive Domains Among Older Adults With Controlled and Uncontrolled Glycemia. The journals of gerontology Series A, Biological sciences and medical sciences. 2024;79. https:\/\/doi.org\/10.1093\/gerona\/glae136","DOI":"10.1093\/gerona\/glae136"},{"key":"2591_CR65","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1038\/s41467-021-23508-y","volume":"12","author":"K Shaw","year":"2021","unstructured":"Shaw K, Bell L, Boyd K, Grijseels DM, Clarke D, Bonnar O, et al. Neurovascular coupling and oxygenation are decreased in hippocampus compared to neocortex because of microvascular differences. Nat Commun. 2021;12:3190. https:\/\/doi.org\/10.1038\/s41467-021-23508-y.","journal-title":"Nat Commun"},{"key":"2591_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0006-8993(02)02953-0","volume":"948","author":"NR Bhat","year":"2002","unstructured":"Bhat NR, Fan F. Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res. 2002;948:93\u2013101. https:\/\/doi.org\/10.1016\/s0006-8993(02)02953-0.","journal-title":"Brain Res"},{"key":"2591_CR67","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature09613","volume":"468","author":"D Attwell","year":"2010","unstructured":"Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010;468:232\u201343. https:\/\/doi.org\/10.1038\/nature09613.","journal-title":"Nature"},{"key":"2591_CR68","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1021\/acscentsci.9b00770","volume":"5","author":"KSS Lee","year":"2019","unstructured":"Lee KSS, Yang J, Niu J, Ng CJ, Wagner KM, Dong H, et al. Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways. ACS Cent Sci. 2019;5:1614\u201324. https:\/\/doi.org\/10.1021\/acscentsci.9b00770.","journal-title":"ACS Cent Sci"},{"key":"2591_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb1206","author":"A Ghosh","year":"2020","unstructured":"Ghosh A, Comerota MM, Wan D, Chen F, Propson NE, Hwang SH, et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.abb1206.","journal-title":"Sci Transl Med"},{"key":"2591_CR70","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0495.1000300","author":"A Ulu","year":"2016","unstructured":"Ulu A, Inceoglu B, Yang J, Singh V, Vito S, Wulff H, et al. Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotension. J Clin Toxicol. 2016. https:\/\/doi.org\/10.4172\/2161-0495.1000300.","journal-title":"J Clin Toxicol"},{"key":"2591_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411995","author":"E Ahremenko","year":"2025","unstructured":"Ahremenko E, Andreev A, Apushkin D, Korkotian E. Glial cells in the early stages of neurodegeneration: pathogenesis and therapeutic targets. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms262411995.","journal-title":"Int J Mol Sci"},{"key":"2591_CR72","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.14336\/ad.2023.1010","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu W, Geng P, Du W, Guo C, Wang Q, et al. Role of Crosstalk between Glial Cells and Immune Cells in Blood-Brain Barrier Damage and Protection after Acute Ischemic Stroke. Aging Dis. 2023;15:2507\u201325. https:\/\/doi.org\/10.14336\/ad.2023.1010.","journal-title":"Aging Dis"},{"key":"2591_CR73","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1023\/b:nere.0000021246.96864.89","volume":"29","author":"E Ambrosini","year":"2004","unstructured":"Ambrosini E, Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res. 2004;29:1017\u201338. https:\/\/doi.org\/10.1023\/b:nere.0000021246.96864.89.","journal-title":"Neurochem Res"},{"key":"2591_CR74","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jcp.21356","volume":"215","author":"KS Moshal","year":"2008","unstructured":"Moshal KS, Zeldin DC, Sithu SD, Sen U, Tyagi N, Kumar M, et al. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol. 2008;215:771\u201381. https:\/\/doi.org\/10.1002\/jcp.21356.","journal-title":"J Cell Physiol"},{"key":"2591_CR75","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison IF, Ismail O, Machhada A, Colgan N, Ohene Y, Nahavandi P, et al. Impaired glymphatic function and clearance of tau in an Alzheimer\u2019s disease model. Brain. 2020;143:2576\u201393. https:\/\/doi.org\/10.1093\/brain\/awaa179.","journal-title":"Brain"},{"key":"2591_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.33696\/neurol.5.087","volume":"5","author":"X Fang","year":"2024","unstructured":"Fang X, Fan F, Border JJ, Roman RJ. Cerebrovascular Dysfunction in Alzheimer\u2019s Disease and Transgenic Rodent Models. J Exp Neurol. 2024;5:42\u201364. https:\/\/doi.org\/10.33696\/neurol.5.087.","journal-title":"J Exp Neurol"},{"key":"2591_CR77","doi-asserted-by":"publisher","first-page":"885787","DOI":"10.3389\/fnagi.2022.885787","volume":"14","author":"EG Thomas","year":"2022","unstructured":"Thomas EG, Rhodius-Meester H, Exalto L, Peters SAE, van Bloemendaal L, Ponds R, et al. Sex-specific associations of diabetes with brain structure and function in a geriatric population. Front Aging Neurosci. 2022;14:885787. https:\/\/doi.org\/10.3389\/fnagi.2022.885787.","journal-title":"Front Aging Neurosci"},{"key":"2591_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173451","author":"S Nuthikattu","year":"2022","unstructured":"Nuthikattu S, Milenkovic D, Norman JE, Rutledge J, Villablanca A. The brain\u2019s microvascular response to high glycemia and to the inhibition of soluble epoxide hydrolase is sexually dimorphic. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14173451.","journal-title":"Nutrients"},{"key":"2591_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051214","author":"JE Norman","year":"2023","unstructured":"Norman JE, Nuthikattu S, Milenkovic D, Rutledge JC, Villablanca AC. Sex-specific response of the brain free oxylipin profile to soluble epoxide hydrolase inhibition. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15051214.","journal-title":"Nutrients"},{"key":"2591_CR80","doi-asserted-by":"publisher","first-page":"e70328","DOI":"10.1002\/hbm.70328","volume":"46","author":"HA Deery","year":"2025","unstructured":"Deery HA, Moran C, Liang EX, Gurvich C, Egan GF, Jamadar SD. Sex Differences in the Association of Cerebral Blood Flow and Glucose Metabolism in Normative Aging. Hum Brain Mapp. 2025;46:e70328. https:\/\/doi.org\/10.1002\/hbm.70328.","journal-title":"Hum Brain Mapp"},{"key":"2591_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tins.2008.11.005","volume":"32","author":"RC Koehler","year":"2009","unstructured":"Koehler RC, Roman RJ, Harder DR. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci. 2009;32:160\u20139. https:\/\/doi.org\/10.1016\/j.tins.2008.11.005.","journal-title":"Trends Neurosci"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02591-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02591-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:16:27Z","timestamp":1791933387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02591-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":81,"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02591-3","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants have consented to the publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.D. Hammock is a founder; S.H. Hwang, C. Morisseau, and J. Yang are employees of EicOsis L.L.C., a startup company with an sEH inhibitor in human clinical trials.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}